Stay updated on Flotetuzumab EAP in AML: Investigational Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab EAP in AML: Investigational Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-03T23:47:08.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record, and the site revision label advances from v3.7.1 to v3.7.2.
    Difference
    1.0%
    Check dated 2026-10-20T23:50:10.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-07T00:17:23.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    A new revision v3.7.0 was added to the study's history and revision v3.6.6 was removed, signaling an update to the study record.
    Difference
    0.1%
    Check dated 2026-09-16T00:01:14.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.6 has been added to the record history, replacing the prior revision v3.6.5. This indicates an update to the study record.
    Difference
    0.1%
    Check dated 2026-09-01T20:01:56.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A new page revision (v3.6.5) was added to the record history and the previous revision (v3.6.4) was removed, reflecting an update to the system's version tracking.
    Difference
    0.1%
    Check dated 2026-08-11T19:13:47.000Z thumbnail image

Stay in the know with updates to Flotetuzumab EAP in AML: Investigational Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.